On January 28, 2020, Charles Lieber, Chair of the Department of Chemistry and Chemical Biology at Harvard University, was arrested and charged in connection with aiding the People’s Republic of China. Dr. Lieber, who served as the Principal Investigator of the Lieber Research Group at Harvard, specializes in nanoscience and has received more than $15,000,000 in funding from the National Institutes of Health (NIH) and Department of Defense (DOD). The charge stems from fraudulent disclosures allegedly made by Dr. Lieber to federal grantors regarding his financial connections to the Chinese government. The criminal prosecution of Dr. Lieber offers a couple of key lessons for federal grantees.
Regulations, Compliance, & Enforcement
Trending Now
A Rare Peek Into FCPA Settlement Amount Negotiations • DOJ Launches FOCUS Initiative to Triage Data Miners Filing Qui Tam FCA Complaints: Key Takeaways • EO 14398 Compliance: Public Comment Period Opens for Federal Contractors • Strategic AI Integration Considerations for In-House Counsel • Need for Speed: What DOJ’s New Approach to the CEP Means for Internal Investigations
Arrest of Harvard Professor Reinforces Heightened Scrutiny of Federal Grant Recipients with Connections to China
J Dennis | Shutterstock
Track False Claims Act cases, audit trends, and compliance best practices with our Compliance & Enforcement newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.